Latest News

  • Alkermes Provides Update on FDA Review of ARISTADAâ„¢ for the Treatment of Schizophrenia Read More
  • Alkermes plc Reports Second Quarter 2015 Financial Results Read More
  • Alkermes to Host Conference Call to Discuss Second Quarter 2015 Financial Results Read More

Investors

Learn More

Working at Alkermes

Join Our Team